Argon Plasma Coagulation in Open Excisional Hemorrhoidectomy
ARGO
1 other identifier
interventional
100
1 country
1
Brief Summary
This prospective single-center randomized clinical trial evaluates whether the use of argon plasma coagulation (APC) during open excisional hemorrhoidectomy reduces postoperative pain and perioperative morbidity compared with conventional monopolar coagulation in adults with symptomatic grade III-IV hemorrhoids requiring surgical treatment. A total of 100 participants will be randomized in a 1:1 ratio to open hemorrhoidectomy performed with APC or open hemorrhoidectomy performed with monopolar coagulation. In two arms, the severity of pain will be assessed from day 1 to day 7 postoperatively, both before and after taking analgesics. Additional assessments will be conducted on days 14 and 28 post-surgery, as well as during the first and second defecation using a visual analog scale (VAS). Early postoperative complications, including intraoperative and postoperative bleeding, burning sensation and itching will be evaluated. Long-term complications such as anal canal stenosis, perianal scar deformation, and disease recurrence will be assessed six months after surgery using digital examination performed by consultant proctologist. The goal of this clinical trial is to discover the safety and efficacy of open excisional hemorrhoidectomy for hemorrhoids III-IV grade using argon plasma coagulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 5, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedMay 18, 2026
May 1, 2026
2.6 years
April 5, 2026
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity before taking analgesics on postoperative day 4
Postoperative pain intensity will be assessed using the visual analog scale (VAS; 0 = no pain, 10 = worst imaginable pain). The primary analysis will compare the VAS pain scores on postoperative day 4, before taking analgesics;
Assessment on the fourth postoperative day
Secondary Outcomes (14)
Postoperative pain intensity on day 14
Assessment on the postoperative day 14
Postoperative pain intensity after the first defecation
At the day of the first defecation during first week after surgery
Intraoperative bleeding
During surgery
Postoperative bleeding
From surgery through postoperative day 28
Rate of Participants with postoperative burning sensation and itching
From surgery through postoperative day 28
- +9 more secondary outcomes
Study Arms (2)
argon plasma coagulation- APC-arm
EXPERIMENTALA total of 100 participants will be randomized in a 1:1 ratio to open hemorrhoidectomy performed with APC or open hemorrhoidectomy performed with monopolar coagulation. In APC arm will be 50 participants.Patients aged ≥18 years with symptomatic grade III -IV hemorrhoids refractory to conservative treatment will eligible for inclusion. Exclusion criteria are: * external hemorrhoids thrombosis * patients with grade I-II hemorrhoids * acute and chronic anal fissures * requiring combined interventions * previous surgical interventions for hemorrhoids like a rubber band ligation * sclerotherapy or laser hemorrhoidplasty (LHP) * pregnancy * Any known anorectal malignancy or suspicion of malignancy * Significant systemic diseases (severe cardiovascular disease, severe hepatic dysfunction)
open hemorrhoidectomy using monopolar coagulation
ACTIVE COMPARATORIn MC arm will be 50 participants
Interventions
After spinal anesthesia and positioning in lithotomy, the external component of the hemorrhoidal cushion will be grasped with Allis forceps, followed by its traction medially. Using argon plasma coagulation at the "cut" mode (power - 40W), an initial incision will be made in the peri-anal skin above the external hemorrhoidal node. Then, using "argon plasma coagulation" mode (power - 40W), the internal and external hemorrhoidal components will undergo dissection from the sphincters down to the vascular pedicle with preservation of mucocutaneous bridges. The vascular pedicle will be coagulated using the APC and cut. The tips of the surgery include non-suturing approach to vascular pedicle and non-touch technique to the preserved tissue for reducing pain severity. APC may allow to perform bloodless surgery due to welding of vessels.
In the MC arm, participants will undergo the same open excisional hemorrhoidectomy technique, but tissue dissection and hemostasis will be performed using standard monopolar coagulation according to institutional routine practice
Eligibility Criteria
You may not qualify if:
- external hemorrhoids thrombosis
- patients with grade I-II hemorrhoids
- acute and chronic anal fissures
- requiring combined interventions
- previous surgical interventions for hemorrhoids like a rubber band ligation
- sclerotherapy or laser hemorrhoidplasty (LHP)
- pregnancy
- Any known anorectal malignancy or suspicion of malignancy
- Significant systemic diseases (severe cardiovascular disease, severe hepatic dysfunction)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinical Hospital №4, Sechenov University, Moscow, Russia
Moscow, Moscow, 101000, Russia
Related Publications (2)
Efetov S, Otabekov A, Koziy A. Seamless open excisional haemorrhoidectomy-Six faces of surgical technique: A Video Vignette. Colorectal Dis. 2024 Jul;26(7):1478-1479. doi: 10.1111/codi.17009. Epub 2024 May 21. No abstract available.
PMID: 38773684BACKGROUNDEfetov S, Rebrova A, Volgin M, Koziy AY, Zubayraeva A. Argon plasma coagulation in two-step procedure for surgical treatment of huge circular four-stage haemorrhoids - A video vignette. Colorectal Dis. 2025 Sep;27(9):e70237. doi: 10.1111/codi.70237. No abstract available.
PMID: 40990073BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sergey K Efetov, MD, PhD
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Efetov Sergey
Study Record Dates
First Submitted
April 5, 2026
First Posted
May 14, 2026
Study Start
August 1, 2023
Primary Completion
March 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 18, 2026
Record last verified: 2026-05